Your browser doesn't support javascript.
loading
The promise and harms of screening for plasma cell dyscrasias.
Mohyuddin, Ghulam Rehman; Chakraborty, Rajshekhar; Cliff, Edward R Scheffer.
Afiliação
  • Mohyuddin GR; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Chakraborty R; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA.
  • Cliff ERS; Program on Regulation, Therapeutics and Law, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Br J Haematol ; 200(6): 704-707, 2023 03.
Article em En | MEDLINE | ID: mdl-36626939
ABSTRACT
In this perspective, we highlight both the promise and harms of screening for plasma cell dyscrasias, as well as the implications of the use of mass spectrometry for diagnosing monoclonal gammopathy of undetermined significance in routine practice.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraproteinemias / Gamopatia Monoclonal de Significância Indeterminada / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraproteinemias / Gamopatia Monoclonal de Significância Indeterminada / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article